Xiaohua Zeng

10PUBLICATIONS
27CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Panel data analysisSimulation, modelling, and programming of mechatronics systemsTe ariā o ngā tauira panoni hauora o te Māori (Māori theory of change models for health)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 05, 2026
Promoter Hypermethylation-Induced Silencing of FXYD1 Drives Breast Cancer Metastasis via DDX5-Mediated Wnt/β-Catenin Pathway Activation.

Ping Wen, Fanli Qu, Long Wang

|Nov 25, 2025
Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial.

Jun-Jie Li, Wen-Juan Zhang, Xiao-Hua Zeng

|Aug 18, 2025
Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2- Breast Cancer.

Xiu-Zhi Zhu, Hu-Yun-Long Zhang, Yi-Fan Zhou

|Jun 29, 2025
C1QL1 inhibits breast cancer through the HSP90α/VCP-ERS/UPR axis.

Ningning Zhang, Qing Shao, Xinni Xiang

|Jan 29, 2025
Global, Regional, and National Burden of Male Breast Cancer, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021.

Long Wang, Ping Wen, Qing Shao

|Oct 02, 2024
A Phase II Clinical Study on Apatinib Plus Vinorelbine in Refractory HER2-Negative Breast Cancer and its Metabolic Implications of Drug Resistance.

Jing Wu, Pan Deng, La Zou

Pageof 2

Frequent Collaborators

1 joint publications

Jun-Jie Li

1 joint publications

Jiong Wu

1 joint publications

Guang-Yu Liu

1 joint publications

Zhi-Ming Shao